- Home
- BR vs DXCM Comparison
BR vs DXCM Comparison
Compare BR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BR | DXCM |
|---|---|---|
| Founded | 1962 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6B | 25.9B |
| IPO Year | 2007 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BR | DXCM |
|---|---|---|
| Price | $227.85 | $67.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 21 |
| Target Price | ★ $259.83 | $86.86 |
| AVG Volume (30 Days) | 673.6K | ★ 4.7M |
| Earning Date | 01-30-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 35.12 | 7.75 |
| EPS | ★ 7.82 | 1.80 |
| Revenue | ★ $7,055,600,000.00 | $4,515,900,000.00 |
| Revenue This Year | $8.71 | $17.38 |
| Revenue Next Year | $4.75 | $12.76 |
| P/E Ratio | ★ $29.18 | $37.61 |
| Revenue Growth | 8.57 | ★ 14.21 |
| 52 Week Low | $212.33 | $54.11 |
| 52 Week High | $271.91 | $93.25 |
Technical Indicators
Market Signals| Indicator | BR | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 60.01 |
| Support Level | $226.30 | $65.56 |
| Resistance Level | $228.84 | $67.95 |
| Average True Range (ATR) | 3.31 | 1.74 |
| MACD | -0.11 | 0.07 |
| Stochastic Oscillator | 30.60 | 58.66 |
Price Performance
Historical ComparisonAbout BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two operating segments: investor communication solutions and global technology and operations.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.